国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Actinobacillus succinogenes Probable GTP-binding protein EngB (engB) CSB-YP410382AUG
CSB-EP410382AUG
CSB-BP410382AUG
CSB-MP410382AUG
CSB-EP410382AUG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Actinobacillus succinogenes 50S ribosomal protein L31 (rpmE) CSB-YP410383AUG
CSB-EP410383AUG
CSB-BP410383AUG
CSB-MP410383AUG
CSB-EP410383AUG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Actinobacillus succinogenes Ketol-acid reductoisomerase (ilvC) CSB-YP410384AUG
CSB-EP410384AUG
CSB-BP410384AUG
CSB-MP410384AUG
CSB-EP410384AUG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Actinobacillus succinogenes Histidine biosynthesis bifunctional protein hisB (hisB) CSB-YP410385AUG
CSB-EP410385AUG
CSB-BP410385AUG
CSB-MP410385AUG
CSB-EP410385AUG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Actinobacillus succinogenes Sec-independent protein translocase protein TatA (tatA), partial CSB-YP410386AUG
CSB-EP410386AUG
CSB-BP410386AUG
CSB-MP410386AUG
CSB-EP410386AUG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Actinobacillus succinogenes 30S ribosomal protein S21 (rpsU) CSB-YP410387AUG
CSB-EP410387AUG
CSB-BP410387AUG
CSB-MP410387AUG
CSB-EP410387AUG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Actinobacillus succinogenes 50S ribosomal protein L9 (rplI) CSB-YP410388AUG
CSB-EP410388AUG
CSB-BP410388AUG
CSB-MP410388AUG
CSB-EP410388AUG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Actinobacillus succinogenes ATP-dependent Clp protease ATP-binding subunit ClpX (clpX) CSB-YP410389AUG
CSB-EP410389AUG
CSB-BP410389AUG
CSB-MP410389AUG
CSB-EP410389AUG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Actinobacillus succinogenes UPF0307 protein Asuc_0809 (Asuc_0809) CSB-YP410390AUG
CSB-EP410390AUG
CSB-BP410390AUG
CSB-MP410390AUG
CSB-EP410390AUG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Actinobacillus succinogenes Deoxycytidine triphosphate deaminase (dcd) CSB-YP410391AUG
CSB-EP410391AUG
CSB-BP410391AUG
CSB-MP410391AUG
CSB-EP410391AUG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Actinobacillus succinogenes Amino-acid acetyltransferase (argA) CSB-YP410392AUG
CSB-EP410392AUG
CSB-BP410392AUG
CSB-MP410392AUG
CSB-EP410392AUG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Actinobacillus succinogenes 3-phosphoshikimate 1-carboxyvinyltransferase (aroA) CSB-YP410393AUG
CSB-EP410393AUG
CSB-BP410393AUG
CSB-MP410393AUG
CSB-EP410393AUG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Actinobacillus succinogenes UPF0283 membrane protein Asuc_0957 (Asuc_0957), partial CSB-YP410394AUG1
CSB-EP410394AUG1
CSB-BP410394AUG1
CSB-MP410394AUG1
CSB-EP410394AUG1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Actinobacillus succinogenes Iron-sulfur cluster insertion protein ErpA (erpA) CSB-YP410395AUG
CSB-EP410395AUG
CSB-BP410395AUG
CSB-MP410395AUG
CSB-EP410395AUG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Actinobacillus succinogenes Outer-membrane lipoprotein carrier protein (lolA) CSB-YP410396AUG
CSB-EP410396AUG
CSB-BP410396AUG
CSB-MP410396AUG
CSB-EP410396AUG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Actinobacillus succinogenes Ribosome-binding factor A (rbfA) CSB-YP410397AUG
CSB-EP410397AUG
CSB-BP410397AUG
CSB-MP410397AUG
CSB-EP410397AUG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Actinobacillus succinogenes UPF0756 membrane protein Asuc_1151 (Asuc_1151), partial CSB-YP410398AUG1
CSB-EP410398AUG1
CSB-BP410398AUG1
CSB-MP410398AUG1
CSB-EP410398AUG1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Actinobacillus succinogenes Anthranilate phosphoribosyltransferase (trpD) CSB-YP410399AUG
CSB-EP410399AUG
CSB-BP410399AUG
CSB-MP410399AUG
CSB-EP410399AUG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Actinobacillus succinogenes UPF0745 protein Asuc_1390 (Asuc_1390) CSB-YP410400AUG
CSB-EP410400AUG
CSB-BP410400AUG
CSB-MP410400AUG
CSB-EP410400AUG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Actinobacillus succinogenes Alanine racemase (alr) CSB-YP410401AUG
CSB-EP410401AUG
CSB-BP410401AUG
CSB-MP410401AUG
CSB-EP410401AUG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達載體的選擇、表達蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達載體?

表達載體是一種DNA分子,它攜帶特定的基因進入宿主細胞,并利用細胞的蛋白質(zhì)合成機制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達載體可使外源基因在宿主細胞中高效表達,經(jīng)過多年的發(fā)展,表達載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達載體。

第三條:如何表達具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達服務(wù),您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>